Draksha (Grape): Benefits, Evidence & Safety
TL;DR
Draksha is the Ayurvedic name for the grape (Vitis vinifera); Ayurvedic reviews describe the dried fruit (raisin) as the classical drug form. Meta-analyses of randomized trials link grape products to modest improvements in cholesterol and systolic blood pressure, but resveratrol-supplement results cannot be equated with eating grapes. Dietary grapes are ordinary food; concentrated extracts lack long-term safety data in humans.
What it is
Draksha is the Ayurvedic name for the grape, Vitis vinifera L. (family Vitaceae). The Ayurvedic Pharmacopoeia of India includes a monograph for Draksa defining its identity, purity, and strength (peer-reviewed review of draksha). In the research literature, "grape products" is a broad category, table grapes, raisins (dried grapes), juice, powder, and extracts, and these are not interchangeable with resveratrol, a single polyphenol from grape skin that is studied at supplement doses far above what diet provides. That distinction runs through everything below.
Traditional use
Charaka Samhita (Sutra 4/8) lists draksha in the Kasahara Mahakashaya: the group of cough-relieving drugs (IJSDR review). The classical literature describes it as sweet in taste with a cooling potency and a vatapittahara action (pacifying vata and pitta), and regards it as a rasayana (rejuvenative) that nourishes the tissues. Classical indications listed in the review include thirst (trishna), fever (jwara), cough (kasa), breathing difficulty (shwasa), burning sensation (daha), wasting (shosha), jaundice (kamla), and bleeding disorders (raktapitta) (IJSDR review). These are traditional claims, not clinical proof: the trial evidence is assessed separately below.
What modern research says
Blood lipids (meta-analysis of RCTs)
A 2020 meta-analysis of randomized controlled trials of grape products (including grape juice and extracts) on lipid profile found, versus placebo: total cholesterol −7.6 mg/dL, LDL cholesterol −6.3 mg/dL, triglycerides −14.5 mg/dL, and HDL cholesterol +1.4 mg/dL, with oxidized LDL and apolipoprotein B also lower (Lupoli et al., PMC). These are modest changes, smaller than drug therapy, and varied across trials.
Blood pressure (meta-analysis of RCTs)
A meta-analysis of 10 studies of grape polyphenols found systolic blood pressure fell by 1.48 mmHg versus control, while diastolic pressure did not change significantly (PMC). The authors called the reduction modest compared with antihypertensive medications and called for larger, better-designed trials specifically in hypertensive subjects.
Inflammation and antioxidant markers (meta-analysis of 29 RCTs)
A systematic review and meta-analysis of 29 randomized controlled trials of whole grape products, grape juice, powder, raisins, currants, and pomace, explicitly excluding grape seed extract and resveratrol, reported consistent improvements in antioxidant markers (catalase, ORAC, total antioxidant capacity) and reduced TBARS, an indicator of lipid peroxidation, but no significant overall effect on circulating inflammatory markers (hsCRP, IL-6, TNF-α, MCP-1). In subgroup analysis, whole grape extract (as opposed to fresh or dried grape) did significantly reduce hsCRP and TNF-α (Nutrients review).
Resveratrol supplements are not grapes (meta-analyses of RCTs)
Resveratrol is one grape-skin polyphenol; trials use isolated resveratrol at doses (≥100 mg/day, up to ≥1,000 mg/day) far beyond dietary intake, so these results do not transfer to eating grapes or raisins:
- Liu et al. 2017: 9 RCTs, 283 patients with type 2 diabetes: resveratrol improved fasting plasma glucose (−0.29 mmol/L), insulin levels, and HOMA-IR insulin-resistance scores, and reduced systolic and diastolic blood pressure. Changes in HbA1c, LDL, and HDL were negligible, and doses ≥100 mg/day looked more favorable (PubMed).
- Gu et al. 2022: 19 RCTs, 1,151 patients with type 2 diabetes: resveratrol at ≥1,000 mg/day reduced fasting blood glucose (−18.76 mg/dL), systolic BP (−7.97 mmHg), and diastolic BP (−3.55 mmHg), with no improvement in waist circumference, triglycerides, or HDL (PMC).
These are supplement data in diabetic patients: not evidence that grapes treat diabetes, and not a reason to take resveratrol pills.
Dosage
No medicinal dose of draksha is established. Trial interventions varied widely, juices, powders, and extracts, and the blood-pressure meta-analysis noted a median polyphenol dose of 733 mg/day across its included studies, which is a description of the trials, not a recommended dose. Dietary grape intake is food, not a dosed medicine.
Safety & contraindications
Grapes and raisins are ordinary dietary foods. Concentrated grape extracts and high-dose resveratrol supplements were studied only short-term in trials, so long-term safety data are lacking. People managing diabetes should account for the sugars in grape juice and raisins within their overall diet. As with any concentrated supplement, check potential interactions with medications with a clinician or pharmacist.
FAQs
Is draksha good for the heart?
Grape-product trials show modest signals: a meta-analysis of RCTs found small improvements in cholesterol fractions and triglycerides, and another found a small systolic blood pressure reduction (PMC; PMC). These are risk-marker changes, not proof of fewer heart events.
Do raisins lower blood pressure?
Raisins were included among the whole grape products in the meta-analyses, but no raisin-specific trial claim can be made; the pooled systolic effect for grape polyphenols was small (−1.48 mmHg) (PMC).
Is resveratrol the same as grape extract?
No. Resveratrol is one isolated grape-skin polyphenol studied at supplement doses (≥100–1,000 mg/day) far above dietary intake; its trial results do not transfer to eating grapes, raisins, or drinking grape juice (PubMed; PMC).
What is draksha in Ayurveda?
The Ayurvedic name for the grape (Vitis vinifera), classed classically as a cough-relieving (kasahara), vata-pitta-pacifying, rejuvenative (rasayana) fruit (IJSDR review).
Are there side effects?
Grapes and raisins as foods have no specific safety warnings from the trial literature. Concentrated extracts and high-dose resveratrol lack long-term safety data; people with diabetes should count the sugars in juice and raisins.
Sources
- Lupoli R et al. "Impact of Grape Products on Lipid Profile: A Meta-Analysis of Randomized Controlled Studies." 2020 — PMC · PMC7073656
- "Effect of Grape Polyphenols on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials." 2015 — PMC · PMC4572713
- "Effects of Grape and Grape-Derived Bioactives on Inflammation and Immune-Driven Mechanisms Within the Context of Cardiometabolic Health and Aging: A Review." Nutrients. — mdpi.com
- Liu K et al. "Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis." Nutrition Research. 2017 — PubMed · PMID 29018489
- Gu et al. "Effects of Resveratrol on Metabolic Indicators in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis." Int J Clin Pract. 2022 — PMC · PMC9158797
- "Ayurvedic Review of Draksha (Vitis vinifera Linn.) and Its Effect on Kasa as a part of Charakokta Kasahara Mahakashaya." IJSDR. 2022 — ijsdr.org
Related herbs
Disclaimer
This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.